These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 34948277)

  • 21. Cell death and inflammation: the case for IL-1 family cytokines as the canonical DAMPs of the immune system.
    Martin SJ
    FEBS J; 2016 Jul; 283(14):2599-615. PubMed ID: 27273805
    [TBL] [Abstract][Full Text] [Related]  

  • 22. COVID-19 and Neutrophils: The Relationship between Hyperinflammation and Neutrophil Extracellular Traps.
    Borges L; Pithon-Curi TC; Curi R; Hatanaka E
    Mediators Inflamm; 2020; 2020():8829674. PubMed ID: 33343232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Molecular mechanisms of inflammasome activation during microbial infections.
    Broz P; Monack DM
    Immunol Rev; 2011 Sep; 243(1):174-90. PubMed ID: 21884176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Damage-Associated Molecular Patterns and the Systemic Immune Consequences of Severe Thermal Injury.
    Comish PB; Carlson D; Kang R; Tang D
    J Immunol; 2020 Sep; 205(5):1189-1197. PubMed ID: 32839211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How is inflammation initiated? Individual influences of IL-1, IL-18 and HMGB1.
    Keyel PA
    Cytokine; 2014 Sep; 69(1):136-45. PubMed ID: 24746243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms and pathways of innate immune activation and regulation in health and cancer.
    Cui J; Chen Y; Wang HY; Wang RF
    Hum Vaccin Immunother; 2014; 10(11):3270-85. PubMed ID: 25625930
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Can Natural Killer Cells Be a Principal Player in Anti-SARS-CoV-2 Immunity?
    Ahmed F; Jo DH; Lee SH
    Front Immunol; 2020; 11():586765. PubMed ID: 33365027
    [No Abstract]   [Full Text] [Related]  

  • 28. Alternative functions for the multifarious inflammasome.
    Martel J; Lai HC; Ko YF; Young JD; Ojcius DM
    Biomed J; 2016 Jun; 39(3):183-7. PubMed ID: 27621119
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human Nasal and Lung Tissues Infected
    Alfi O; Yakirevitch A; Wald O; Wandel O; Izhar U; Oiknine-Djian E; Nevo Y; Elgavish S; Dagan E; Madgar O; Feinmesser G; Pikarsky E; Bronstein M; Vorontsov O; Jonas W; Ives J; Walter J; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    J Virol; 2021 Jun; 95(14):e0013021. PubMed ID: 33893170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.
    Li S; Zhang Y; Guan Z; Li H; Ye M; Chen X; Shen J; Zhou Y; Shi ZL; Zhou P; Peng K
    Signal Transduct Target Ther; 2020 Oct; 5(1):235. PubMed ID: 33037188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Severe immunosuppression and not a cytokine storm characterizes COVID-19 infections.
    Remy KE; Mazer M; Striker DA; Ellebedy AH; Walton AH; Unsinger J; Blood TM; Mudd PA; Yi DJ; Mannion DA; Osborne DF; Martin RS; Anand NJ; Bosanquet JP; Blood J; Drewry AM; Caldwell CC; Turnbull IR; Brakenridge SC; Moldwawer LL; Hotchkiss RS
    JCI Insight; 2020 Sep; 5(17):. PubMed ID: 32687484
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alarmins, inflammasomes and immunity.
    Saïd-Sadier N; Ojcius DM
    Biomed J; 2012; 35(6):437-49. PubMed ID: 23442356
    [TBL] [Abstract][Full Text] [Related]  

  • 33. COVID-19 and immunity: quo vadis?
    Miyasaka M
    Int Immunol; 2021 Sep; 33(10):507-513. PubMed ID: 33569606
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond.
    Kunze FA; Hottiger MO
    Trends Immunol; 2019 Feb; 40(2):159-173. PubMed ID: 30658897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inflammasome as a promising therapeutic target for cancer.
    Lee C; Do HTT; Her J; Kim Y; Seo D; Rhee I
    Life Sci; 2019 Aug; 231():116593. PubMed ID: 31228512
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coronavirus-19 (SARS-CoV-2) induces acute severe lung inflammation via IL-1 causing cytokine storm in COVID-19: a promising inhibitory strategy.
    Conti P; Caraffa A; Gallenga CE; Ross R; Kritas SK; Frydas I; Younes A; Ronconi G
    J Biol Regul Homeost Agents; 2020; 34(6):1971-1975. PubMed ID: 33016027
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The complement system, toll-like receptors and inflammasomes in host defense: three musketeers' one target.
    Kumar V
    Int Rev Immunol; 2019; 38(4):131-156. PubMed ID: 31066339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synergism of TNF-α and IFN-γ Triggers Inflammatory Cell Death, Tissue Damage, and Mortality in SARS-CoV-2 Infection and Cytokine Shock Syndromes.
    Karki R; Sharma BR; Tuladhar S; Williams EP; Zalduondo L; Samir P; Zheng M; Sundaram B; Banoth B; Malireddi RKS; Schreiner P; Neale G; Vogel P; Webby R; Jonsson CB; Kanneganti TD
    Cell; 2021 Jan; 184(1):149-168.e17. PubMed ID: 33278357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NLRs, inflammasomes, and viral infection.
    Jacobs SR; Damania B
    J Leukoc Biol; 2012 Sep; 92(3):469-77. PubMed ID: 22581934
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treating COVID-19 with colchicine in community healthcare setting.
    Della-Torre E; Della-Torre F; Kusanovic M; Scotti R; Ramirez GA; Dagna L; Tresoldi M
    Clin Immunol; 2020 Aug; 217():108490. PubMed ID: 32492478
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.